Infant formula
This article was originally published in The Tan Sheet
Executive Summary
FDA requests comments on existing requirements that infant formula manufacturers notify FDA if their products are found to "not provide the nutrients required" or if the products are adulterated or misbranded. In these instances, the agency evaluates the risk of the problem and may require a recall. The request for comments on the proposed extension of the reporting requirements for infant formula is required under the Paperwork Reduction Act. Comments are due April 26